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Abstract.  We have found a  regional distribution of IL 
1/3 mRNA and IL 1 activity in the normal adult rat 
brain,  which reveals at least partially a  colocalization 
with nerve growth factor (NGF).  The predominantly 
neuronal signal patterns were found over the granule 
cells of the dentate gyrus, the pyramidal cells of the 
hippocampus, the granule cells of the cerebellum, the 
granule and periglomerular cells of the olfactory bulb, 
and over dispersed cells of the ventromedial 
hypothalamus and of the frontal cortex.  In these areas 
also the highest levels of IL 1 activity were observed. 
In the striatum and septum much lower levels of IL 1/3 
mRNA and IL 1 activity (shown for the striatum), 
most likely synthesized by glial cells, could be deter- 
mined. IL 1/3-expressing cells were mainly found in 
brain regions that also synthesize NGF mRNA as 
shown by in situ hybridization. NGF mRNA could be 
demonstrated over pyramidal cells of the hip- 
pocampus, granule cells of the dentate gyrus, 
periglomerular cells of the olfactory bulb and over 
prefrontal cortex neurons. These data indicate that IL 
113, among other factors, might also play a  regulatory 
role in the synthesis of NGF in the CNS,  as has been 
demonstrated in the peripheral nervous system (Lind- 
holm, D.,  R.  Heumann, M.  Meyer, and H.  Thoenen. 
1987.  Nature  (Lond.).  330:658-659). 
T 
HE  physiological  function  of  nerve  growth  factor 
(NGF) ~  for specific populations of neui~ons of the pe- 
ripheral  and central  nervous  systems is well docu- 
mented.  NGF is essential for the development and main- 
tenance of function of the peripheral sympathetic and neural 
crest-derived sensory neurons (see Levi-Montalcini and An- 
geletti, 1968; Thoenen and Barde, 1980; Green and Shooter, 
1980).  In the central nervous system a similar function of 
NGF has recently been established for cholinergic neurons 
of the  basal  forebrain  nuclei  (see  Thoenen et al.,  1987; 
Whittemore and  Seiger,  1987).  Whereas  the  function of 
NGF  as  a  retrograde  messenger transferring information 
from the field of innervation to the NGF-responsive innervat- 
ing neurons was unambiguously established, very little is 
known  about  the  mechanisms  involved in  the  regionally 
differential regulation of NGF synthesis. In the peripheral 
nervous system, we have recently demonstrated that lesion- 
ing of the sciatic nerve leads to a dramatic increase in NGF 
synthesis by nonneuronal cells (Heumann et al.,  1987 a,b). 
It could also be demonstrated that at least the long-lasting 
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1. Abbreviation used in this paper:  NGF,  nerve growth factor. 
augmentation of NGF synthesis is mediated by immigrat- 
ing macrophages. Of the many cytokines synthesized and re- 
leased by macrophages IL 1 was shown to be the predomi- 
nantly responsible agent for the regulation of the reactive 
synthesis of NGF (Lindholm et al.,  1987, 1988).  Interest- 
ingly, IL l-like activity has also been found in the normal rat 
brain (Nieto-Sampedro and Berman, 1987), which increases 
after injury. However, the site of synthesis and the physiolog- 
ical functions are unknown. More recently, we have demon- 
strated that IL-1 induces the synthesis of NGF in astrocytes 
in vitro and increases also the NGF mRNA levels in hip- 
pocampus after intraventricular injections (Spranger et al., 
1990).  These results suggest that also in the CNS IL-1 has 
the  potential  to  regulate  NGF  synthesis.  However,  from 
these experiments it could not be deduced whether IL 1 is 
also involved in the physiological regulation of NGF syn- 
thesis. 
We now demonstrate that IL 1/3 mRNA and IL 1 activity 
are partially colocalized with NGF mRNA in certain brain 
regions of the normal adult rat. In situ hybridization experi- 
ments show a predominantly neuronal expression of both the 
IL 1/3 mRNA and the NGF mRNA, which indicates that IL 
1/3 might indeed play a functional role in the regulation of 
NGF synthesis in the CNS. 
©  The Rockefeller University Press, 0021-9525/90/10/1701/11  $2.00 
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Cell Culture 
Primary Brain Cultures. Cerebri of newborn rats were processed by the 
method of McCarthy and DeVellis (1980).  Cells were seeded in 75-cm Fal- 
con flasks  and cultivated in DME medium (Gibco Laboratories, Paisley, 
Scotland) with 10% FCS (Gibco Laboratories) for 2 wk at 10% CO2. The 
medium was changed every fourth day. The cell monolayer was taken off 
with 0.1% trypsin/5 mM EDTA (Sigma Chemical Co., St. Louis, MO), trit- 
urated, and replated on poly-L-lysine (Sigma Chemical Co.) coated four- 
well Greiner dishes with 10,000 cells/well. 2 d before use for in situ hybrid- 
ization the cells were switched to serumless DME medium (Spranger et al., 
1990). 
Cerebellar Granule Cells. Granule cells were prepared from cerebella 
of 7-d-old rats by trypsin treatment (0.1% [vol/vol], 15 min; Balazs et al., 
1988; Hatten et al., 1988). The cells were cultured for 3 d on poly-L-lysine- 
coated dishes (5/~g/ml) in a medium consisting of one part of Eagle's basal 
medium with Earle's salts (Gibco Laboratories), one part of Ham's F12 
medium with 33 mM glucose and 2 mM glutamine and the following sup- 
plements: 25  ~g/ml insulin,  100 t~g/ml transferrin, 20 nM progesterone, 
100 I~M putrescine, 30 nM selenium (Bottenstein and Sato, 1979). Cytosine 
arabinoside (10  ~tM) was  routinely  added to  the cultures  to  inhibit the 
growth of nonneuronal cells. Granule cells were identified by their small 
size and by the extensive outgrowth of neurites during the first days of cul- 
ture (Balazs et al.,  1988;  Hatten et al.,  1988). 
Activated Macrophages. Activated rat peritoneal macrophages were ob- 
tained as described by Lindholm et al. (1988) and Heumann et al. (1987b). 
Raising of Polyclonal Rat IL 1[3 Antibodies 
The NH2-terminal peptide of mature rat IL  1/~ (amino acids  117-143 ac- 
cording to Nishida et al. [1988] with an additional tyrosine at position 144) 
was synthesized on a peptide synthesizer (model 431A; Applied Biosystems, 
Foster City, CA) using Fmoc chemistry. New Zealand White Rabbits were 
immunized with native, uncoupled peptide by standard protocols. In ELISA 
tests using the peptide adsorbed to plastic as a solid phase (Flanders et al., 
1988) the serum had a titer of 10  -4 after the third booster injection. 
Figure 1. Schematic presentations of the 
localization  of  IL-1/3  mRNA  (a)  and 
NGF mRNA  (b)  in the adult rat brain. 
The sites of synthesis are dotted and rep- 
resent  the  hippocampus  (CA1-CA3), 
cerebellar granule  cells (GrA),  granule 
and periglomerular cells of the olfactory 
bulb, neurons in the frontal cortex, and 
neurons of the ventromedial hypothala- 
mus (VMH).  Not shown are hybridiza- 
tions oflL 1/3 mRNA in the striatum and 
septum. Abbreviations and drawings af- 
ter  Pellegrino et al.  (1979). 
The Journal  of Cell Biology,  Volume 111, 1990  1702 Figure 2.  Results from in situ hybridization of rat brain sagittal sections to IL 1/40  riboprobes. Positive IL 1~3 hybridizations are shown 
for the hippocampus (a),  the granule cells of the cerebellum (c), periglomerular cells of the olfactory bulb (e) with the corresponding 
phase contrast photomicrograph (f),  neurons of the hypothalamus (g), and neurons of the frontal cortex (h). No specific labeling is seen 
on sections hybridized with the sense IL 1/40- probe (b and d). Positive labeling is also shown over glial cells in the septum (j) and stria- 
tum (l) with the corresponding phase contrast pictures (i and k). Background labeling is shown of a section through the striatum hybridized 
with the sense IL 1/40- riboprobe (m). All sections were counterstained with cresyl-violet. Exposure time was 5.5 wk at 4°C.  Bars, (a-d) 
1 mm;  (e-m) 50 tLm. 
Bandtlow et al. Expression of IL 113 and NGF mRNA in Rat Brain  1703 Figure 3.  Higher magnifications of the positive IL  1/~ mRNA hy- 
bridization signals found over granule cells of the dentate gyrus (a), 
the cerebellum  (b),  and the periglomerular cells of the olfactory 
bulb (c),  indicating a  differential expression of the IL  1/3 mRNA. 
Note, that the Purkinje cells (arrows) in the cerebellum are not la- 
beled (b).  Exposure time was 4  wk at 4°C.  Bar,  100/.tm. 
Costimulator Assay  for ILI Activity 
After transcardial perfusion of adult Wistar  rats (180-200  g)  with Dul- 
becco's modified Eagle's medium (Sigma Chemical Co.), brains were rap- 
idly dissected. Corresponding brain regions of  each animal were pooled and 
stored at -70°C. Samples were homogenized in 500 #1/100 mg wet weight 
of  buffer H (50 mM NaC1,  10 mM Hepes, 1 mM EDTA 20/xM 2-mercapto- 
ethanol, 0.1  mM PMSE 2  ~g/ml Pepstatin A, pH 7.0) by  10 strokes in a 
glass Teflon homogenizer. After removal of membranes by sequential low- 
speed (12,000  g, 5 rain, 4°C) and high-speed centrifugation (TLA  100.3 
rotor; 50,000  rpm,  15 min, 4°C, Beckman Instruments, Fullerton, CA), 
samples were analyzed by FPLC using a Superose 12 column (HR 10/30, 
Pharmacia Fine Chemicals, Piscataway,  NJ). Elution was performed with 
150  mM NaCI,  50  mM  Na2HPO4,  pH 7.4,  collecting 500  #1  fractions. 
Myoglobin and lysozyme (Sigma Chemical Co.) were used as molecular 
weight standards. IL 1 activity was assessed for each fraction at a one-tenth 
dilution as described by LeMoal et al.  (1988)  using the EL4 cell clone as 
indicator of IL 2 receptor expression. The assay was modified to a three- 
step procedure applying biotinylated second antibodies and streptavidin- 
coupled  peroxidase  (Amersham  Chemicals).  The  sensitivity  limit  was 
"~10  -6 U per assay of human recombinant IL 1/3 (Biogen, Geneva, Switzer- 
land) used as an internal standard. As an additional positive control dilu- 
tions of conditioned medium from activated rat macrophages were assayed. 
Neither NGF (up to 50 ng/ml) nor IL-6 (up to 200 U/ml) were active in 
this assay. Analysis by the described method of 1 U of recombinant human 
IL  1/3  in 5%  FCS resulted in 70-85%  recovery of activity.  To exclude 
specific differences  in inhibition or degradation of endogenous IL 1 activity, 
samples of brain regions were homogenized after addition of recombinant 
IL 1/3 in 10-fold excess over the average of endogenous IL 1 activity.  In all 
cases the recovery was 70%. 
All experiments for immunoadsorption were done with an IgG fraction 
(called B-IgG) prepared by protein A-Sepharose chromatography from the 
bleeding after the third boost. The immunoadsorption columns contained 
50/zl of packed preswollen protein A-Sepharose. 100 #g of B-IgG or, for 
control columns, the same amount of  commercial rabbit IgG (Miles Labora- 
tories, Naperville, IN) in 600 #1 of 150 mM Tris, pH 8.8 were passed twice 
over the column. For immunoadsorption the column was washed with 1 ml 
of culture  medium used  for EL-4 cells (RPMI  1640,  5%  FCS,  20  /zM 
2-mercaptoethanol, 12 mM Hepes; R-medium). 50 #1 of the most active 
fraction from the preceding Superose 12 chromatography step were passed 
over the immunoadsorption or the control column. Thereafter the column 
was washed twice with 50 ~tl of R-medium and the flow through as well as 
the washes were pooled and applied on a second column of the same type. 
The flowthrough and the washes of this column were pooled and tested at 
a one-fifth dilution in the EL-4 costimulator assay. 
In Situ Hybridization 
Adult Wistar rats (180-200 g) were ether anaethesized and transcardially 
perfused with prewarmed 4%  paraformaldehyde/PBS (Fluka AG;  Buchs, 
Switzerland) for 30 min. Brains were removed, immersed in the fixative for 
2 h, before being incubated in 15%  sucrose/PBS overnight at 4°C. Brains 
were then frozen and 10-/xm sagittal sections were collected on (50 #g/ml; 
Sigma  Chemical  Co.)  coated  poly-L-lysine glass  slides.  Cultures  were 
treated with the same fixative for 30 min before thorough washing with PBS. 
Slides and cultures were further processed as described by Bandtlow et al. 
(1987),  including an acetylation step before prehybridization (Hayashi et 
al.,  1978). 
Conditions for IL 1~3-specific Probes.  To get IL  l~-specific probes of 
a defined length and sequence a synthetic oligonucleotide of 40 bases (base 
777-816 of the mouse IL 1/3 cDNA; Gray et al. [1986]) was subcloned into 
the Bluescript vector (Promega Biotech, Madison, WI). The sequence for 
the oligonucleotide was selected  by the following criteria: (a) low homology 
to mouse IL lt~ to ensure specific hybridization to IL 1~; (b) high homology 
to human IL-1/3 to increase the probability that mouse and rat IL 113 is de- 
tected by the probe; and (c) low homology to 28S ribosomal RNA to reduce 
nonspecific binding. In vitro 35S-labeled  sense (IL:-1/3/40-)  and antisense 
(IL-1/3/40  +) transcripts of linearized plasmids were made as recommended 
by the manufacturer (Pmmega Biotec). In comparison, we also used 35S- 
labeled single-strand DNA probes obtained by reverse transcription of non- 
labeled sense and antisense transcripts. These probes resulted in a similar 
specific activity of 8  x  108 cpm/#g and were used under the same condi- 
tions as for cRNA probes, with the exception that the RNase A digestion 
step was omitted. Single stranded RNA or DNA probes were diluted to 
30,000  cpm/#l  in  the  following hybridization  buffer:  50%  formamide, 
The Journal  of Cell Biology,  Volume 111, 1990  1704 Figure  4.  Localization  of  IL  1~ 
mRNA in primary brain cultures of 
newborn rats after 2 d in vitro under 
low serum conditions (0.5%  FCS). 
Dark  field  (a),  the  corresponding 
bright field (b),  and phase-contrast 
(c) photomicrographs showing a se- 
lective labeling of ~5 % of the cells. 
Exposure time was 3 wk at 4°C. Figure 5. Northern blot of total RNA from purified cerebellar gran- 
ule cells and of RNA from activated rat macrophages, hybridized 
with the 32p-labeled IL 1~/450 riboprobe. Cells had been in cul- 
ture for 4 d;  RNA was extracted and processed as described in 
Materials  and Methods.  Positions of the  ribosomal  18 and 28S 
RNA are  indicated. The filters were RNase-treated and the ex- 
posure time for neuronal RNA (lefO was four times longer than that 
of  activated macrophages (right). Roughly 5/~g total neuronal RNA 
was loaded in all lanes, whereas total macrophage RNA was ap- 
plied to a two-time dilution series of 5 #g. 
0.6 M NaC1, 10 mM Tris, pH 7.0, 0.05 % yeast total RNA (Sigma Chemical 
Co.), 2 ×  Denhardt's, 0.05 % inorganic sodium pyrophosphate, 10 mM me- 
thionine,  10 ~M  nonlabeled thio-UTP (New England Nuclear,  Dreieich, 
FRG), 20 mM ~-mercaptoethanol. Prehybridization (2 h) and hybridization 
(12 h) were carried out at 45°C. Thereafter, cultures and slides were rinsed 
several times with 2× SSC and washed three times for 30 min in 0.2x SSC 
at 40°C. Cells and sections were then treated with RNase A  (15/~g/ml in 
0.5 M NaCI, 10 mM Tris, pH 8, 1 mM EDTA) at 37°C for 30 min, followed 
by a wash in RNase buffer for 15 min, before they were finally washed in 
0.1×  SSC  for  15  min at  55°C.  Culture dishes and slides were  then de- 
hydrated, air dried, dipped in Kodak NTB 3 emulsion and exposed at 4°C. 
Autoradiographs were counterstained with cresyl violet after development. 
Conditions for NGF-specificprobes. A fragment of 118 bp from the cod- 
ing region of the mouse NGF cDNA (amino acid  188-227;  Scott et al., 
1983)  was subcloned into the Bluescript vector (Promega Biotec). Nonla- 
beled sense and antisense transcripts were reverse transcribed in the pres- 
ence of 35S-labeled  dGTP.  Hybridization was carried out in the above de- 
scribed buffer at 50°C. Washing steps were performed three times in 0.2 × 
SSC at 50°C for 30 min and finally in 0.1× SSC, 25% formamide at 50°C. 
Slides were further processed as described above. 
Northern Blot Analysis 
Total cellular RNA from cultured cerebellar granule cells was isolated and 
further processed for Northern blot analysis as described by Lindholm et 
al. (1988).  Briefly, RNA was glyoxylated and electrophoresed through a 1.2% 
agarose gel. After transfer of RNA to nylon membranes (Hybond; Amer- 
sham Chemicals) hybridization was carried out at 60°C in the presence of 
50% formamide as described previously (Heumann et al., 1987a). The IL 1 
clone used for Northern blots was prepared by the polymerase chain reac- 
tion (PCR) using oligonucleotides constructed against two regions of the 
mouse IL-I~ cDNA (amino acids 53-58 and 207-213 for the sense and anti- 
sense oligonucleotides,  respectively)  (Young  and  Sylvester,  1989).  The 
cDNA used was obtained by reverse transcription of RNA from activated 
rat macrophages. The rat IL 1~ clone (450 bp) was further subcloned into 
the bluescript vector and sequenced and 32P-labeled  cRNA run-off tran- 
scripts were used at a concentration of 2  ×  106 cpm/ml for Northern blot 
hybridization.  After hybridization the filters were washed at 55°C in 2× 
SSC for 30 min and exposed to x-ray films. The specificity of the rat IL 
1/3 probe was shown by RNase A  treatment of the Northern blots and by 
comparison with RNA from activated macrophages. 
Results 
In Situ Hybridization 
To determine the cellular localization of the specific expres- 
sion of the IL 1/~ and NGF mRNA, sagittal sections of adult 
rat brains were hybridized with 35S-labeled antisense DNA- 
or cRNA- probes (IL 1/3/40+; NGF/ll8÷).  Control sections 
were hybridized under the same conditions with 35S-labeled 
sense DNA- or cRNA- probes (IL 1~/40-;  NGF/ll8-). The 
autoradiographic results are summarized in Fig.  1, by sche- 
matic presentations of the sites oflL 1/3 and NGF expression. 
Localization of lL 113 mRNA 
Cell bodies hybridizing to the IL 1~/40  + probe were found 
in the hippocampal pyramidal cell layer, the granule cells of 
the dentate gyrus (Fig. 2, a and b), the granule cells of the 
cerebellum (Fig. 2, c and d), the granule and periglomerular 
cells of the olfactory bulb (Fig. 2,  e and f), disperse cells 
of the anterior hypothalamus (Fig. 2 g), and of the frontal 
cortex (Fig. 2 h). A higher magnification of the labeling pat- 
tern in the dentate gyrus suggests a differential expression of 
the IL 1~ mRNA since not all cell bodies of the granule cells 
are labeled (Fig. 3 a). The same is even more evident for the 
periglomerular cells of the olfactory bulb, where the signal 
is present only over a few cells (Fig. 3 c). In contrast, in the 
cerebellum, where exclusively granule cells were labeled, 
the grain distribution was intense and equal (Fig.  3 b).  A 
consistent but much weaker labeling was detected over the 
striatum and septum (Fig. 2, i-m).  However, in these brain 
areas the grains were homogenously distributed in between 
the neurons which are spared, suggesting that most probably 
glial cells are responsible for the signal. In comparison, no 
labeling occurred in brain regions rich in oligodendrocytes 
such as the corpus callosum (data not shown), indicating that 
oligodendrocytes do not contribute to the specific IL 1/3 sig- 
nal in situ. These results are consistent with in situ hybridiza- 
tion experiments done on unstimulated primary cultures of 
newborn rat brains. In these cultures, consisting of oligoden- 
drocytes, astrocytes, fibroblasts and microglia cells, only a 
very small number of cells ('~5 %) express IL 1~ under se- 
rum free conditions (Fig. 4).  Although it was  not possible 
to identify the labeled cells unequivocally, they could well 
present amoeboid microglia cells since the number of la- 
beled cells correlated with the  number of microglia cells 
found under these culture conditions by immunocytochemi- 
cal staining (Spranger et al.,  1990).  The neuronal identity 
of IL l~-containing cells was further assessed by Northern 
blot analysis of cultured cerebellar granule cells from 7-d-old 
rats. These purified cells produce a typical 1.6-1.7 kb IL 1B 
transcript (Fig. 5) as described for macrophages (Giulian et 
al.,  1986). However, as demonstrated in Fig. 5, the cerebel- 
lar granule cells contain a much lower copy number of IL 
1~ as compared with activated macrophages. The presence 
of IL 1~ in cultured cerebellar granule cells was additionally 
confirmed by in situ hybridization as shown in Fig.  6, and 
reflects the sensitivity of the detection system. 
Localization of NGF mRNA 
Similar labeling patterns as described for IL 1/3 were found 
for the distribution of NGF mRNA.  As has been shown by 
others (Rennert and Heinrich,  1986; Ayer-Le Li~vre et al., 
1988;  Whittemore et  al.,  1988)  labeled  cell  bodies  were 
found in the pyramidal cell layer of the hippocampus and in 
the granule cell layer of the dentate gyrus (Fig. 7 a). Interest- 
ingly, in this particular region the labeling signal found for 
NGF strikingly resembles the pattern seen for IL  1~ (see 
Fig.  2 a),  suggesting that both messages might be synthe- 
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Figure 8. Column-fractionation of IL 1 activity. Frontal cortex ho- 
mogenate (of 40 mg wet wt) has been applied on a Superose 12 
column.  Fractions that eluted between 14 and  17 kD have been 
measured (see Materials and Methods) for their IL 1 activity. The 
absorbance at 280 nm was continuously monitored (dotted line). 
All the IL 1 activity eluted as a single peak at 16 kD (straight line). 
Molecular weight markers: myoglobin (M;  17 kD) and lysozyme 
(L; 14.7 kD). 
sized within the same cells. Labeled neurons were also ob- 
served in the cerebral cortex, restricted over neurons in the 
frontal  cortex,  however,  complete  identification  of these 
cells was not possible (Fig. 7 c). In addition we could now 
detect  cell  bodies  hybridizing  with  the  NGF/ll8  ÷ DNA 
probe over the periglomerular cells  of the olfactory bulb 
(Fig. 7 b), whereas no signal above background was seen in 
sections hybridized with the control probe NGF/118-. (Fig. 
7 d). As seen for the IL 1 mRNA, the specific labeling over 
periglomerular cells varied from strongly positive neurons 
to  negative  ones,  presumably  reflecting differential NGF 
synthesis by individual neurons. 
IL 1 Activity 
The IL 1 assay we used was a costimulator assay measuring 
IL 2 receptor expression induced on EIA cells by IL 1 and 
a suboptimal dose of a phorbolester (LeMoal et al.,  1988). 
Preliminary experiments showed that rat blood contains a 
phorbol  ester  independent  activity  (constituent of 30-40 
kD), which drastically interfered with the bioassay used. We 
therefore decided to perfuse the animals and to fractionate 
the tissue samples by FPLC to separate other IL 2 receptor 
inducing activities as described by Tagaya et al. (1988). The 
peak activity found in various brain regions eluted slightly 
later than myoglobin (17 kD) and before tysozyme (14 kD) 
at a position corresponding to '~16 kD (Fig. 8). For compari- 
son >80 % of the IL 1 activity of the conditioned medium 
from activated rat macrophage cultures eluted at the same 
position (data not shown). Since macrophages release a vari- 
ety of factors that could possibly interfere with our assay sys- 
tem we take this finding as a proof for the specificity of the 
method. Determination of the IL 1 activity in various brain 
regions after fractionation closely resembled the distribution 
pattern found by in situ hybridization. Although the values 
of corresponding tissue  samples  varied between  different 
animals, they reflect a regionally consistent distribution of 
the IL 1 activity in all examined rat brains. The highest activ- 
ity levels were found in the olfactory bulb, hippocampus, 
cerebellum, and the frontal cortex, reaching maximal levels 
of 10  -3 U/mg wet weight (Table I). In comparison, IL 1 ac- 
tivity found in conditioned medium from activated rat mac- 
rophages (per  106 cells) was  -,500-1,000 U.  A  1,000-fold 
lower, but consistent level was observed in the striatum (Ta- 
ble I), where in situ hybridizations have indicated that proba- 
bly glial ceils are the IL l~-specific source. The specificity 
of these values was further proven by the fact that rat specific 
polyclonal antibodies raised against IL 1 could adsorb up to 
93 % of the IL 1 activity found in frontal cortex or cerebel- 
lum (Table I). 
Discussion 
The only information on a possible involvement of IL 1~ in 
the regulation of NGF synthesis in the CNS is based on the 
augmentation of NGF mRNA in the hippocampus after in- 
traventricular injections of IL 1/3 (Spranger et al.,  1990). 
However,  these  experiments  did  not  provide  evidence 
whether IL 1/8 also plays a role in the regulation of NGF syn- 
thesis under physiological conditions. We have now iden- 
tified the cell types and areas in the adult rat brain that syn- 
thesize IL 1~ mRNA as well as NGF mRNA, and found a 
regional colocalization of both mRNAs. NGF was shown to 
be regionally distributed in the mammalian brain, with the 
highest levels in areas innervated by magnocellular neurons 
present in the basal forebrain (Korsching et al.,  1985; Shel- 
ton and Reichardt,  1986; Whittemore et al.,  1986). Due to 
the limiting amounts of NGF mRNA a precise cellular local- 
ization has been successfully demonstrated only over the py- 
ramidal cell layer of the hippocampus, granule cells of the 
dentate gyrus and over neurons found in the neocortex (Ren- 
nert  and  Heinrich,  1986;  Ayer-Le  Li~vre  et  al.,  1988; 
Whittemore et al.,  1988). These results are consistent with 
RNA blot analysis showing that hippocampus and neocortex 
have the highest NGF mRNA levels (see Korsching, 1987). 
The olfactory bulb is another area known to express NGF 
mRNA in relatively high quantities (see Korsching,  1987). 
In this paper we have shown by in situ hybridization that the 
periglomerular cells are the specific source of NGF mRNA 
in this region. Interestingly, periglomerular cells are inter- 
neurons lying in the glomerular layer which receives cholin- 
ergic input (Halasz and Sheperd, 1983), which demonstrates 
again that the target cells synthesize NGE Of particular in- 
Table L IL-I Activity in Different Brain Regions of Three 
Individual Animals 
IL 1 activity 
Region  Animal  Animal  Animal  Average  SD 
10  -s  U/mg  wet wt 
Olfactory  1.25  1.5  0.1  0.95  0.75 
Frontal cortex*  0.25  0.5  1.25  0.67  0.52 
Hippocampus  1.0  0.5  0.5  0.67  0.29 
Cerebellum*  0.5  0.13  0.5  0.37  0.21 
Striatum  0.0  0.0025  0.0005  0.0025  0.0025 
* One frontal cortex and one cerebellum were analyzed by the immunoadsorb- 
tion protocol  given in  Materials and Methods.  Compared with the control 
columns 93% (cerebellum) and 90% (frontal  cortex) of the IL 1 activity  were 
adsorbed. 
Tissues have been fractionated by gel filtration  and IL-1 activity was analyzed 
as described in Materials and Methods. 
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for NGF coincides with the determination of IL  1 activity. 
In addition, in situ hybridization demonstrated that IL 113 is 
predominantly expressed by neurons, which were shown to 
be positive  for NGE  However,  IL  1/3 was also present in 
other brain regions such as the hypothalamus, striatum, and 
septum, where the levels of NGF mRNA are at best at the 
limit of detectability (Whittemore et al.,  1986),  suggesting 
that IL-1/3 must have a  different  or additional function in 
these tissues (Breder et al.,  1988).  It is of interest that ex- 
cept for the hypothalamus glial cells are most likely respon- 
sible for the expression of IL  1~ mRNA in these brain tis- 
sues. However, it was not possible to unequivocally identify 
whether astrocytes and/or microglial cells contain the IL 1/~ 
mRNA. Both cell types have been shown to synthesize IL-1 
in vitro (Fontana et al., 1982; Giulian et al., 1986) but there 
is no evidence for a production under physiological condi- 
tions. Although we could demonstrate a partial colocaliza- 
tion of IL  1/3 and NGF, suggesting that IL 1/3 might be in- 
volved in the regulation of NGF synthesis also in the CNS, 
the physiological relevance of the observed results are ham- 
pered by the fact that hydropathicity profiles of IL 1/~ precur- 
sor apparently lack any regions that have sufficient hydropho- 
bicity and length to qualify as a signal peptide (Lomedico 
et al.,  1984).  Whether IL  1 can be secreted despite these 
apparent  shortcomings  remains  an  open  question.  Recent 
reports have shown that only monocytes secrete IL 1 in both 
the precursor and the mature form (Hazuda et al.,  1988), 
whereas transfected fibroblast cell lines were not able to re- 
lease any of the two forms,  despite a high level expression 
of the IL 1/~ precursor within the cells (Young et al.,  1988). 
It is therefore likely that the used fibroblast cell lines lack 
some cellular factor(s) that allow the secretion and release 
of the intracellular IL  lB.  To evaluate the function of IL  1 
in the regulation of NGF synthesis under physiological con- 
ditions in the CNS it remains to be established whether neu- 
rons use a release mechanism similar to the one described 
for monocytes and how neuronal IL 1 synthesis and release 
is regulated. 
We wish to thank M. Sch6rnig for perfusion of the rats, Drs. A. Lawetzky 
and T. Hiinig for the EL-4 cell  line,  A. Hohn for the plasmid NGF/ll8, 
B. Hengerer for his help in cloning the IL 1~/115, W. Risau for synthesis 
of the peptide,  and Dr.  P. Carroll for improving  the English. 
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